(Total Views: 465)
Posted On: 08/17/2020 4:20:53 PM
Post# of 145915
CtMedic - No, that's not the message I am intending to convey. As I posted, IF we are granted an EUA, then I can't see how the FDA will require us to also do a Phase 3 trial where some patients enrolling know that there's a chance they will only get a placebo whereas patients could get Leron under the EUA. If anything, the FDA could require a Phase 4 where Cytodyn would need to track the status of patients receiving Leron under the EUA and report back to the FDA on a routine basis.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)